vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.

SouthState Bank Corp is the larger business by last-quarter revenue ($661.7M vs $510.9M, roughly 1.3× Genius Sports Ltd). SouthState Bank Corp runs the higher net margin — 34.1% vs -12.3%, a 46.5% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 37.4%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.

GENI vs SSB — Head-to-Head

Bigger by revenue
SSB
SSB
1.3× larger
SSB
$661.7M
$510.9M
GENI
Higher net margin
SSB
SSB
46.5% more per $
SSB
34.1%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
37.4%
SSB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
SSB
SSB
Revenue
$510.9M
$661.7M
Net Profit
$-63.0M
$225.8M
Gross Margin
25.2%
Operating Margin
-11.5%
15.1%
Net Margin
-12.3%
34.1%
Revenue YoY
Net Profit YoY
153.5%
EPS (diluted)
$2.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
SSB
SSB
Q1 26
$661.7M
Q4 25
$510.9M
$581.1M
Q3 25
$335.4M
$599.7M
Q2 25
$215.2M
$577.9M
Q1 25
$119.7M
$544.5M
Q4 24
$413.0M
$369.8M
Q3 24
$285.8M
$351.5M
Q2 24
$184.1M
$350.3M
Net Profit
GENI
GENI
SSB
SSB
Q1 26
$225.8M
Q4 25
$-63.0M
$247.7M
Q3 25
$246.6M
Q2 25
$-47.3M
$215.2M
Q1 25
$-25.5M
$89.1M
Q4 24
$-85.5M
$144.2M
Q3 24
$-47.1M
$143.2M
Q2 24
$-35.5M
$132.4M
Gross Margin
GENI
GENI
SSB
SSB
Q1 26
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Operating Margin
GENI
GENI
SSB
SSB
Q1 26
15.1%
Q4 25
-11.5%
54.3%
Q3 25
-15.3%
53.6%
Q2 25
-21.0%
48.8%
Q1 25
-20.3%
22.3%
Q4 24
-18.0%
50.7%
Q3 24
-13.9%
53.1%
Q2 24
-16.8%
49.3%
Net Margin
GENI
GENI
SSB
SSB
Q1 26
34.1%
Q4 25
-12.3%
42.6%
Q3 25
41.1%
Q2 25
-22.0%
37.2%
Q1 25
-21.3%
16.4%
Q4 24
-20.7%
39.0%
Q3 24
-16.5%
40.7%
Q2 24
-19.3%
37.8%
EPS (diluted)
GENI
GENI
SSB
SSB
Q1 26
$2.28
Q4 25
$2.47
Q3 25
$2.42
Q2 25
$2.11
Q1 25
$0.87
Q4 24
$1.88
Q3 24
$1.86
Q2 24
$1.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
SSB
SSB
Cash + ST InvestmentsLiquidity on hand
$280.6M
$2.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$9.0B
Total Assets
$1.1B
$68.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
SSB
SSB
Q1 26
$2.9B
Q4 25
$280.6M
Q3 25
$110.2M
Q2 25
$110.2M
Q1 25
$110.2M
Q4 24
$100.3M
Q3 24
$100.3M
Q2 24
$100.3M
Stockholders' Equity
GENI
GENI
SSB
SSB
Q1 26
$9.0B
Q4 25
$724.5M
$9.1B
Q3 25
$572.4M
$9.0B
Q2 25
$572.4M
$8.8B
Q1 25
$572.4M
$8.6B
Q4 24
$573.0M
$5.9B
Q3 24
$573.0M
$5.9B
Q2 24
$573.0M
$5.7B
Total Assets
GENI
GENI
SSB
SSB
Q1 26
$68.0B
Q4 25
$1.1B
$67.2B
Q3 25
$792.3M
$66.0B
Q2 25
$792.3M
$65.9B
Q1 25
$792.3M
$65.1B
Q4 24
$775.7M
$46.4B
Q3 24
$775.7M
$46.1B
Q2 24
$775.7M
$45.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
SSB
SSB
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
SSB
SSB
Q1 26
Q4 25
$81.9M
$232.1M
Q3 25
$-4.8M
$122.4M
Q2 25
$-1.2M
$72.6M
Q1 25
$-14.6M
$-126.3M
Q4 24
$14.9M
$354.3M
Q3 24
$-9.2M
$-246.8M
Q2 24
$126.8M
Free Cash Flow
GENI
GENI
SSB
SSB
Q1 26
Q4 25
$69.6M
$215.5M
Q3 25
$-14.2M
$101.7M
Q2 25
$-5.8M
$52.5M
Q1 25
$-16.0M
$-139.1M
Q4 24
$11.3M
$340.9M
Q3 24
$-11.6M
$-254.2M
Q2 24
$117.3M
FCF Margin
GENI
GENI
SSB
SSB
Q1 26
Q4 25
13.6%
37.1%
Q3 25
-4.2%
17.0%
Q2 25
-2.7%
9.1%
Q1 25
-13.4%
-25.5%
Q4 24
2.7%
92.2%
Q3 24
-4.1%
-72.3%
Q2 24
33.5%
Capex Intensity
GENI
GENI
SSB
SSB
Q1 26
Q4 25
2.4%
2.9%
Q3 25
2.8%
3.5%
Q2 25
2.1%
3.5%
Q1 25
1.2%
2.4%
Q4 24
0.9%
3.6%
Q3 24
0.9%
2.1%
Q2 24
2.7%
Cash Conversion
GENI
GENI
SSB
SSB
Q1 26
Q4 25
0.94×
Q3 25
0.50×
Q2 25
0.34×
Q1 25
-1.42×
Q4 24
2.46×
Q3 24
-1.72×
Q2 24
0.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

SSB
SSB

Net Interest Income$561.6M85%
Noninterest Income$100.1M15%

Related Comparisons